Alpha Cognition - ACOG Company Short-Term Debt

Public company logo of Alpha Cognition Inc. (ACOG)

Alpha Cognition (ACOG) specializes in developing therapies for Alzheimer's disease. The current metric stands at 0.00, however, the lack of a steady capital inflow and established distribution channels makes profits unpredictable. This price chart reflects the dynamics of short-term debt. Meanwhile, operating within the US legal framework and the biotech's humanitarian status protect clinical developments from external trade conflicts.

ACOG (Alpha Cognition) Company Short-Term Debts history from 11/13/2024 to 10/28/2026

Summary analytical data breakdowns for Alpha Cognition Inc (ACOG)

- price and consensus price forecast:
Price Chart Alpha Cognition Corp|ACOG - Fair Value Consensus
- market capitalization data:
Market Value Alpha Cognition Inc.|ACOG - Total Enterprise Value
- book capitalization data:
Book Value per Share Alpha Cognition|ACOG - Book Capitalization|Market Value to Book Value Ratio alphacognition.com|ACOG - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Alpha Cognition|ACOG - Long-Term Liabilities to Equity|Short-Term Debt to Capital Alpha Cognition Corp|ACOG - Aggregate Debt Obligations|Debts to Book Capitalization Alpha Cognition Inc.|ACOG - Company Long-Term Debts|Company Current Liabilities Alpha Cognition
Analysis of all company metrics:alphacognition.com (ACOG)
Core merchandise of Alpha Cognition Inc

Monitoring liquidity is critical to isolating the fundamental stability of Alpha Cognition (ACOG) from market noise. This metric aggregates all liabilities maturing within one year, determining the issuer's current solvency. Analyzing short-term obligations allows for an assessment of working capital deficit risks. Amid geopolitical pressure on pharmaceutical logistics, such reserves ensure the continuity of clinical trials. A stable debt level confirms the business's financial resilience during drug development delays.

Competitor analysis

Company Short-Term Debt Biogen (BIIB)|NBIX: Company Short-Term Loans and Borrowings|Company Short-Term Debt RGC|Axsome Corp (AXSM) - Short-Term Debt|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts XENE|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Company Short-Term Debt SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Company Short-Term Debt|Current Liabilities Denali Corp DNLI|Company Short-Term Debts Harmony Biosciences (HRMY)|BHVN - Company Short-Term Loans and Borrowings|AMLX: Company Short-Term Debts|Company Short-Term Debts Trevi Therapeutics Inc|PRAX - Company Current Liabilities|Company Short-Term Loans and Borrowings Anavex Life Sciences Corp|Company Short-Term Debts CBLL (CeriBell, Inc.)|Company Current Liabilities PRTA (Prothena Corporation plc)|ALEC: Company Short-Term Debt|Short-Term Debt Annexon Biosciences ANNX|Company Short-Term Debts OMER|NGNE: Short-Term Indebtedness|Company Short-Term Debt AC Immune|voyagertherapeutics.com (VYGR) - Company Short-Term Indebtedness|NMRA: Company Short-Term Debts|Short-Term Debt Volume Scilex Holding (SCLX)|Company Current Liabilities Tevogen Bio Holdings, Inc.|Amount of Current Liabilities cogrx.com (CGTX)|Company Short-Term Debts IKT|cassavasciences.com - Short-Term Debt Volume|ASRT (Assertio Therapeutics) - Company Short-Term Debt|COYA: Short-Term Debt|Company Short-Term Debt vistagen.com|Ovid Therapeutics (OVID) - Company Short-Term Indebtedness|ABOS (Acumen Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts cervomed.com|Company Short-Term Debts ATHE (Alterity Therapeutics)|Company Current Liabilities CLNN (clene.com)|PEPG: Company Short-Term Debt|Short-Term Debt jupiterneurosciences.com JUNS|Company Short-Term Debts RLMD|ANVS: Short-Term Indebtedness|Company Short-Term Debt gracetx.com|Firefly Neuroscience, Inc. (AIFF) - Company Short-Term Indebtedness|Company Short-Term Debts KLTO (ANEW Medical)|Short-Term Debt NeuroSense Therapeutics, Ltd. (NRSN)|Company Current Liabilities RVPH|Company Short-Term Debts MTVA (metaviatx.com)|Company Short-Term Debt NeurAxis|Helius Medical Technologies, Inc. - Company Short-Term Loans and Borrowings|PASG (Passage Bio Corp) - Company Short-Term Debt|NEUP - Short-Term Debt|NERV: Company Short-Term Debts|ATHA (athira.com) - Company Short-Term Debts|Company Short-Term Debt Addex Therapeutics Ltd|Company Short-Term Debt ALZN|CYCN - Company Short-Term Debt|Current Liabilities protagenic.com (PTIX)|Company Short-Term Debts Pasithea Therapeutics Corp.|Company Short-Term Loans and Borrowings Cortigent Inc CRGT|Avenue Therapeutics, Inc. - Company Short-Term Debts|Brainstorm Cell Therapeutics Inc. (BCLI) - Company Short-Term Debts|Company Current Liabilities Cara Therapeutics, Inc CARA|Chromocell (CHRO) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ELYM|Company Current Liabilities ITCI|Longboard Pharmaceuticals, Inc. - Company Short-Term Debt|Short-Term Debt Marinus Pharmaceuticals Inc (MRNS)|NKGN (NKGen) - Company Short-Term Debts|NeuroBo Pharma - Short-Term Indebtedness|Sage Therapeutics, Inc. (SAGE) - Company Short-Term Debt|SNPX - Company Short-Term Indebtedness|Trevena - Company Short-Term Debts|Short-Term Debt Volume Vigil Neuroscience, Inc.|Anew Medical, Inc. (WENA) - Company Current Liabilities|Amount of Current Liabilities Cerevel Corp